HARBOUR INVESTMENTS, INC. - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 71 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$1,886
-0.6%
500.0%0.00%
Q2 2023$1,897
+56.0%
500.0%0.00%
Q1 2023$1,216
-16.3%
500.0%0.00%
Q4 2022$1,452
-27.4%
500.0%0.00%
Q3 2022$2,0000.0%500.0%0.00%
Q2 2022$2,000
-33.3%
500.0%0.00%
Q4 2021$3,0000.0%500.0%0.00%
Q3 2021$3,000
-25.0%
500.0%0.00%
Q2 2021$4,0000.0%500.0%0.00%
Q1 2021$4,000500.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Claret Asset Management Corp 86,474$6,524,0001.34%
Analyst IMS Investment Management Services Ltd. 28,438$2,143,0000.64%
ALGERT GLOBAL LLC 20,876$1,575,0000.59%
Quantinno Capital Management LP 9,351$706,0000.48%
Crestline Management, LP 37,000$2,792,0000.45%
Empirical Finance, LLC 9,561$721,0000.20%
BRANDES INVESTMENT PARTNERS, LP 55,065$5,469,0000.14%
FORT, L.P. 9,672$730,0000.14%
CAXTON ASSOCIATES LP 8,865$669,0000.13%
ACADIAN ASSET MANAGEMENT LLC 330,448$24,928,0000.11%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders